Cyclacel Pharmaceuticals
CYCC
CYCC
25 hedge funds and large institutions have $5.77M invested in Cyclacel Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.
Holders
25
Holders Change
–
Holders Change %
0%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
6
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$485K |
| 2 |
VKH
2
Virtu KCG Holdings
New York
|
$93K |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$262K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$1.98M |
| 5 |
5
Jane Street
New York
|
$41K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Citigroup
New York
| – | – | -451 | Closed |
|
27
Barclays
London,
United Kingdom
| – | – | -134 | Closed |
|